These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18497307)

  • 1. Counter regulatory effects of PKCbetaII and PKCdelta on coronary endothelial permeability.
    Gaudreault N; Perrin RM; Guo M; Clanton CP; Wu MH; Yuan SY
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1527-33. PubMed ID: 18497307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of PKCbetaII and PKCdelta in blood-brain barrier permeability during aglycemic hypoxia.
    Kim YA; Park SL; Kim MY; Lee SH; Baik EJ; Moon CH; Jung YS
    Neurosci Lett; 2010 Jan; 468(3):254-8. PubMed ID: 19900507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of PKCdelta and PKD in pulmonary microvascular endothelial cell hyperpermeability.
    Tinsley JH; Teasdale NR; Yuan SY
    Am J Physiol Cell Physiol; 2004 Jan; 286(1):C105-11. PubMed ID: 13679307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C-delta inhibition protects blood-brain barrier from sepsis-induced vascular damage.
    Tang Y; Soroush F; Sun S; Liverani E; Langston JC; Yang Q; Kilpatrick LE; Kiani MF
    J Neuroinflammation; 2018 Nov; 15(1):309. PubMed ID: 30400800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes.
    Yuan SY; Ustinova EE; Wu MH; Tinsley JH; Xu W; Korompai FL; Taulman AC
    Circ Res; 2000 Sep; 87(5):412-7. PubMed ID: 10969040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A PKC-beta inhibitor treatment reverses cardiac microvascular barrier dysfunction in diabetic rats.
    Wei L; Yin Z; Yuan Y; Hwang A; Lee A; Sun D; Li F; Di C; Zhang R; Cao F; Wang H
    Microvasc Res; 2010 Jul; 80(1):158-65. PubMed ID: 20079359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKCdelta regulates endothelial basal barrier function through modulation of RhoA GTPase activity.
    Harrington EO; Shannon CJ; Morin N; Rowlett H; Murphy C; Lu Q
    Exp Cell Res; 2005 Aug; 308(2):407-21. PubMed ID: 15935342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.
    Babazono T; Kapor-Drezgic J; Dlugosz JA; Whiteside C
    Diabetes; 1998 Apr; 47(4):668-76. PubMed ID: 9568702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nociceptor beta II, delta, and epsilon isoforms of PKC differentially mediate paclitaxel-induced spontaneous and evoked pain.
    He Y; Wang ZJ
    J Neurosci; 2015 Mar; 35(11):4614-25. PubMed ID: 25788678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.
    Harhaj NS; Felinski EA; Wolpert EB; Sundstrom JM; Gardner TW; Antonetti DA
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5106-15. PubMed ID: 17065532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of protein kinase C is not sufficient to prevent or reverse effects of VEGF165 on claudin-1 and permeability in microvascular retinal endothelial cells.
    Deissler HL; Deissler H; Lang GE
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):535-42. PubMed ID: 19643968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of protein kinase C isoforms in coronary arteries of diabetic mice lacking the G-protein Gα11.
    Hoyer DP; Korkmaz Y; Grönke S; Addicks K; Wettschureck N; Offermanns S; Reuter H
    Cardiovasc Diabetol; 2010 Dec; 9():93. PubMed ID: 21190563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase Cdelta activity.
    Shizukuda Y; Tang S; Yokota R; Ware JA
    Circ Res; 1999 Aug; 85(3):247-56. PubMed ID: 10436167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycaemia promotes cerebral barrier dysfunction through activation of protein kinase C-β.
    Shao B; Bayraktutan U
    Diabetes Obes Metab; 2013 Nov; 15(11):993-9. PubMed ID: 23617822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKCdelta mediates testosterone-induced increases in coronary smooth muscle Cav1.2.
    Maddali KK; Korzick DH; Tharp DL; Bowles DK
    J Biol Chem; 2005 Dec; 280(52):43024-9. PubMed ID: 16243844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential subcellular redistribution of protein kinase C isozymes in the rat hippocampus induced by kainic acid.
    McNamara RK; Wees EA; Lenox RH
    J Neurochem; 1999 Apr; 72(4):1735-43. PubMed ID: 10098884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of migration by protein kinase Calpha and inhibition of proliferation and cell cycle progression by protein kinase Cdelta in capillary endothelial cells.
    Harrington EO; Löffler J; Nelson PR; Kent KC; Simons M; Ware JA
    J Biol Chem; 1997 Mar; 272(11):7390-7. PubMed ID: 9054439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential role of PKC isoforms in GnRH and phorbol 12-myristate 13-acetate activation of extracellular signal-regulated kinase and Jun N-terminal kinase.
    Dobkin-Bekman M; Rahamin-Ben Navi L; Shterntal B; Sviridonov L; Przedecki F; Naidich-Exler M; Brodie C; Seger R; Naor Z
    Endocrinology; 2010 Oct; 151(10):4894-907. PubMed ID: 20810567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKC isoform-specific enhancement of capacitative calcium entry in human corneal epithelial cells.
    Zhang F; Wen Q; Mergler S; Yang H; Wang Z; Bildin VN; Reinach PS
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3989-4000. PubMed ID: 16936115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C (PKC) isoforms translocate to Triton-insoluble fractions in stimulated human neutrophils: correlation of conventional PKC with activation of NADPH oxidase.
    Nixon JB; McPhail LC
    J Immunol; 1999 Oct; 163(8):4574-82. PubMed ID: 10510401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.